Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company’s flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.
Beyond hearing aids and diagnostics, Demant’s product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division. The group also offers accessories and wireless connectivity products that integrate with smartphones and assistive listening devices. Demant’s focus on research and innovation is reflected in its investment in digital platforms and signal-processing technologies aimed at improving speech clarity and user comfort.
Headquartered in Smørum, Denmark, Demant serves customers in more than 130 countries through a network of subsidiaries, distributors and partner clinics. The company operates manufacturing facilities across Europe and Asia, and maintains regional offices in North America and the Asia Pacific to support local markets. Its global presence allows Demant to address diverse regulatory environments and cater to a wide range of clinical practices and consumer preferences.
Founded in 1904 by entrepreneur Hans Demant under the Oticon name, the company was reorganized into the Demant Group and publicly listed in 1995. Over its history, Demant has grown through strategic acquisitions and internal development, reinforcing its position in the hearing health industry. The organization is led by President & CEO Søren Nielsen, supported by an executive leadership team that oversees ongoing innovation, quality assurance and expansion into emerging markets.
AI Generated. May Contain Errors.
